Company Analytics: Mesoblast Limited (ASX: MSB)1216
Mesoblast is a global leader in developing innovative cell-based medicines for the treatment of inflammatory ailments, cardiovascular disease and back pain.
Make a suggestion or report an error on this page: here
Share Price and Volume
Share Price and Volume
This is meant as a quick reference to compare against the other metrics, not as an advanced or accurate share price chart - the share price may be delayed by a day, and the volume by a couple of days.